Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Extra corporeal membrane oxygenation market is for the patient that are suffering from both the heart failure and lung failure which acts as a cardiac and respiratory support. An ECMO machine works as a bypass for the heart and lungs which purifies the blood outside the human body. The global extra corporeal membrane oxygenation market is expected to register a CAGR of 3.6% during the forecast period, 2018 to 2023. North America dominates the market due to the favorable reimbursement scenario and rising incidence of lung cancer in that region.
Increasing incidences of cardiac disorders
Cardiovascular disease are the important cause of the death globally and many people die annually from the cardiovascular diseases than any other cause. According to the WHO 17.7 million people died from the cardiovascular disease which is around 31% of all global deaths and 7.4 million were due to coronary heart disease. These cardiovascular disease are rising due to the unhealthy diet, physical inactivity, tobacco use and excess use of alcohol.
In addition, technological advancement, rising incidence of the chronic obtrusive pulmonary disease (COPD) and increasing number of the cardiac surgeries are fuelling the growth of Global ECMO System Market.
Risk Associated with ECMO Treatment
The ECMO procedure is used to assist the transition from the cardiopulmonary bypass ventilation after heart surgery. There are many risks associated with ECMO machine which are bleeding with the skull and the risk of bleeding is increased if a surgical operation is required as the part of the treatment. Stroke, arteries or veins are being damaged during the ECMO procedure and infection.
In addition, high cost of the ECMO procedure restrict it to be available to some patient which can afford it and presence of alternative techniques other than ECMO are hindering the growth of Global ECMO system Market.
North America to Dominate the Market
The Global ECMO System market is segmented by application of ECMO in various filed such as Cardiac, Respiratory and Extracorporeal Cardiopulmonary Resuscitation. Further, it is also segmented by the type of modality such as Veno-Arterial, Veno-Venous and Arterio-Venous. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America dominates the market due to the favorable reimbursement scenario and rising incidence of lung cancer in that region.
Key Developments in the Market
• October, 2017: LivaNova Receives FDA Approvals for SenTiva Device and Next-Generation Vagus Nerve Stimulation (VNS) Therapy Programming System for Treatment of Epilepsy.
• July, 2017: Castor Branched Aortic Stent-Graft System receives approval from China Food and Drug Administration (CFDA) on 11 July 2017.
Key Players: MEDTRONIC, INC., NIPRO, TERUMO CARDIOVASCULAR SYSTEM CORPORATION, ALUNG TECHNOLOGIES INC, LIVANOVA PLC and MICROPORT SCIENTIFIC CORPORATION
Reasons to purchase this report
• Current and future Global ECMO System Market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Increasing incidences of cardiac disorders
Cardiovascular disease are the important cause of the death globally and many people die annually from the cardiovascular diseases than any other cause. According to the WHO 17.7 million people died from the cardiovascular disease which is around 31% of all global deaths and 7.4 million were due to coronary heart disease. These cardiovascular disease are rising due to the unhealthy diet, physical inactivity, tobacco use and excess use of alcohol.
In addition, technological advancement, rising incidence of the chronic obtrusive pulmonary disease (COPD) and increasing number of the cardiac surgeries are fuelling the growth of Global ECMO System Market.
Risk Associated with ECMO Treatment
The ECMO procedure is used to assist the transition from the cardiopulmonary bypass ventilation after heart surgery. There are many risks associated with ECMO machine which are bleeding with the skull and the risk of bleeding is increased if a surgical operation is required as the part of the treatment. Stroke, arteries or veins are being damaged during the ECMO procedure and infection.
In addition, high cost of the ECMO procedure restrict it to be available to some patient which can afford it and presence of alternative techniques other than ECMO are hindering the growth of Global ECMO system Market.
North America to Dominate the Market
The Global ECMO System market is segmented by application of ECMO in various filed such as Cardiac, Respiratory and Extracorporeal Cardiopulmonary Resuscitation. Further, it is also segmented by the type of modality such as Veno-Arterial, Veno-Venous and Arterio-Venous. By geography it is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa and South America. North America dominates the market due to the favorable reimbursement scenario and rising incidence of lung cancer in that region.
Key Developments in the Market
• October, 2017: LivaNova Receives FDA Approvals for SenTiva Device and Next-Generation Vagus Nerve Stimulation (VNS) Therapy Programming System for Treatment of Epilepsy.
• July, 2017: Castor Branched Aortic Stent-Graft System receives approval from China Food and Drug Administration (CFDA) on 11 July 2017.
Key Players: MEDTRONIC, INC., NIPRO, TERUMO CARDIOVASCULAR SYSTEM CORPORATION, ALUNG TECHNOLOGIES INC, LIVANOVA PLC and MICROPORT SCIENTIFIC CORPORATION
Reasons to purchase this report
• Current and future Global ECMO System Market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares and strategies employed by the major market players.
• 3 months analyst support along with the Market Estimate sheet in excel.
Customization of the report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
